Immune cells in triple-negative breast cancer offer potential therapeutic target

(University of Pennsylvania) New research led by the University of Pennsylvania School of Veterinary Medicine's Rumela Chakrabarti reveals how immune cells called myeloid-derived immunosuppressor cells contribute to the progression of triple-negative breast cancer, a particularly aggressive form of the disease. Pairing chemotherapy with a drug that blocks these cells may one day help stem the cancer's spread.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news